Skip to main content
SpringerLink
Log in

Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy

  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The disposition of cimetidine after oral and intravenous administration during multiple dosing was studied in 11 patients with Laennec's cirrhosis. The average metabolic clearance of cimetidine in these patients was 151/h, similar to values reported for normal subjects. However, in 4 subjects with plasma prothrombin times above normal, the metabolic clearance was significantly decreased and ranged between 4.3 and 13.01/h. The renal clearance of cimetidine was proportional to the creatinine clearance in all subjects, regardless of the severity of the liver disease. The clearance of cimetidine in patients with Laennec's cirrhosis, therefore, appears to be predictabable from creatinine clearance and prothrombin time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Quap CW (1978) Confusion, an adverse reaction to cimetidine therapy. Drug Intell Clin Pharm 12: 121

    Google Scholar 

  2. Agarwal SK (1978) Cimetidine and visual hallucinations. J Am Med Assoc 240: 214

    Article  CAS  Google Scholar 

  3. Wood CA, Isaacson ML, Hibbs ML (1978) Cimetidine and mental confusion. J Am Med Assoc 239: 2550–2551

    Article  CAS  Google Scholar 

  4. Schentag JJ, Calleri G, Rose JQ, Cerra FB, De Glopper E, Bernhard H (1977) Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177–181

    Google Scholar 

  5. Weddington WW Jr, Muelling AE, Moosa HH, Kimball CP, Randall RR (1981) Cimetidine toxic reactions masquerading as delirium tremens. J Am Med Assoc 245: 1058–1059

    Article  Google Scholar 

  6. Schentag JJ, Cerra FB, Calleri GM, Leising ME, French MA, Bernhard H (1981) Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients. Clin Pharmacol Ther 29: 737–743

    Article  PubMed  CAS  Google Scholar 

  7. Gugler R, Müller-Liebenau B, Somogyi A (1982) Altered disposition and availability of cimetidine in liver cirrhotic patients. Br J Clin Pharmacol 14: 421–429

    PubMed  CAS  Google Scholar 

  8. Sonne J, Poulsen HE, Døssing M, Larsen NE, Andreasen PB (1981) Cimetidine clearance and bioavailability in hepatic cirrhosis. Clin Pharmacol Exp 29: 191–197

    CAS  Google Scholar 

  9. Dupont T, Beaugrand M, Brunet J-M, Azouz-Abdallah M, Baylocqu D, Champault G, Ferrier J-P (1981) Etude des concentrations plasmatiques de cimétidine chez des malades cirrhotiques et non cirrhotiques atteints d'hémorragie digestive. Gastroenterol Clin Biol 5: 155–160

    PubMed  CAS  Google Scholar 

  10. Feely J, Wilkinson GR, Wood AJJ (1981) Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 304: 692–695

    PubMed  CAS  Google Scholar 

  11. Jackson JE (1981) Reduction of liver flood flow by cimetidine. N Engl J Med 305: 99–100

    Google Scholar 

  12. Lebrec D, Goldfarb G, Benhamou J-P (1981) Reduction of liver blood flow by cimetidine. J Engl J Med 305: 100

    Google Scholar 

  13. Puurunen J, Sotaniemi E, Pelkonen O (1980) Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol 18: 185–187

    Article  PubMed  CAS  Google Scholar 

  14. Desmond PV, Patwardhan RB, Schenker S, Speeg KV Jr (1980) Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med 93: 266–268

    PubMed  CAS  Google Scholar 

  15. Klotz U, Reimann I (1980) Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam. Eur J Clin Pharmacol 18: 517–520

    Article  PubMed  CAS  Google Scholar 

  16. Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R (1981) Cimetidine decreases theophylline clearance. Am Rev Respir Dis 123: 615–617

    PubMed  CAS  Google Scholar 

  17. Roberts RV, Grice J, Wood, Petroff V, McGuffie C (1981) Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19–21

    PubMed  CAS  Google Scholar 

  18. Richman AV, Marayan JL, Hirschfield JS (1981) Acute interstitial nephritis and acute renal failure associated with cimetidine therapy. Am J Med 70: 1272–1274

    Article  PubMed  CAS  Google Scholar 

  19. Teruel JL, Garcia-Cosmes P, Marcen R, Ortuño J (1981) Renal failure with cimetidine. Ann Intern Med 94: 545

    PubMed  CAS  Google Scholar 

  20. Garibotto G, Giusti M, Bagnasco S, Deferrari G (1981) Effect of long term treatment with cimetidine on PTH levels and renal function in chronic renal failure. IRCS Med Sci 9: 718–719

    CAS  Google Scholar 

  21. Ziichner H (1977) Cholestatische Hepatose unter Cimetidine. Dtsch Med Wochenschr 48: 1788–1789

    Google Scholar 

  22. Villeneuve JP, Warner HA (1979) Cimetidine hepatitis. Gastroenterology 77: 143–144

    PubMed  CAS  Google Scholar 

  23. Lorenzini I, Jezequel AM, Orlandi F (1981) Cimetidine-induced hepatitis. Dig Dis Sci 26: 275–280

    Article  PubMed  CAS  Google Scholar 

  24. Holford NHG (1979) Drugfun. In: Perry HM, Wood JJ (eds) Public procedures notebook. Bolt, Beranek and Newman, Cambridge, Massachusetts

    Google Scholar 

  25. Castleman PA, Russel DH, Webb FN, Hollister CA, Siegel JG, Zdonik SR, Fram DM (1974) The implementation of the PRO-PHET system. Natl Computer Conf Exp Proc 43: 457–468

    Google Scholar 

  26. Yeh KC, Kwan KC (1978) A comparison of numerical integration algorithms by trapezoidal, lagrange, and spline approximation. J Pharmacokinet Biopharm 6: 79–98

    Article  PubMed  CAS  Google Scholar 

  27. Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York, p 175–187

    Google Scholar 

  28. Baig H, Reid-Miller M (1980) Prophet statistics. Bolt Beranek and Newman, Cambridge, Massachusetts pp 12–14

    Google Scholar 

  29. Pedersen PV, Miller R (1980) Pharmacokinetics and bioavailability of cimetidine in humans. J Pharm Sci 69: 394–398

    PubMed  CAS  Google Scholar 

  30. Grahnén A, von Bahr C, Lindström B, Rosén A (1979) Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol 16: 335–340

    Article  PubMed  Google Scholar 

  31. Pancorbo S, Bubrick MP, Chin TWF, Miller KW, Onstad G (1982) Cimetidine dynamics after single intravenous doses. Clin Pharmacol Ther 31: 83–88

    Article  PubMed  CAS  Google Scholar 

  32. Drayer DE, Romankiewicz J, Lorenzo B, Reidenberg MM (1982) Age and renal clearance of cimetidine. Clin Pharmacol Ther 31: 45–50

    Article  PubMed  CAS  Google Scholar 

  33. Griffiths R, Lee RM, Taylor DC (1977) Kinetics of cimetidine in man and experimental animals. In: Burland WL, Alison Simkins M (eds) Cimetidine. 2nd International symposium on H2-receptor antagonists. Excerpta Medica, Amsterdam, pp 38–53

    Google Scholar 

  34. Taylor DC, Crenwell PR, Bartlett DC (1977) The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist, in the rat, dog and man. Drug Metab Dispos 6: 21–30

    Google Scholar 

  35. Walkenstein SS, Dubb JW, Randolph WC, Westlake WJ, Stote RM, Intoccia AP (1978) Bioavailability of cimetidine in man. Gastroenterology 74: 360–365

    PubMed  CAS  Google Scholar 

  36. Ma KW, Brown DC, Masler S, Silvis SE (1978) Effects of renal failure on blood levels of cimetidine. Gastroenterology 74: 473–477

    PubMed  CAS  Google Scholar 

  37. Larsson R, Bodemar G, Norlander B (1979) Oral absorption of cimetidine and its clearance in patients with renal failure. Eur J Clin Pharmacol 15: 153–157

    Article  PubMed  CAS  Google Scholar 

  38. Rowland M, Tozer TN (1980) Clinical pharmacokinetics. Lea and Febiger, Philadelphia, PA, p 222

    Google Scholar 

  39. Galambos JT (1977) Cirrhosis. W. B. Saunders, Philadelphia, PA, p 277

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Division, Department of Medicine, San Francisco General Hospital, San Francisco, California, USA

    J. P. Cello & S. Øie

  2. Department of Pharmacy, University of California, San Francisco, California, USA

    J. P. Cello & S. Øie

Authors
  1. J. P. Cello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Øie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cello, J.P., Øie, S. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy. Eur J Clin Pharmacol 25, 223–229 (1983). https://doi.org/10.1007/BF00543795

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543795

Key words

Search

Navigation